Form 4: Ouster Director Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Ouster Director Ted L. Tewksbury III sold 1,695 shares of common stock for $25.38 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Ted L. Tewksbury III, a Director of Ouster, Inc., reported a sale of common stock.
- The transaction involved the disposition of 1,695 shares of Ouster common stock.
- The shares were sold at a price of $25.38 per share.
- Following this transaction, Ted L. Tewksbury III beneficially owns 125,359 shares of Ouster common stock.
- The sale was executed on November 11, 2025.
- All sale transactions reported were made pursuant to a Rule 10b5-1 trading plan dated August 12, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-arranged Rule 10b5-1 trading plan mitigates concerns that it is based on new, adverse non-public information. It represents a scheduled liquidity event rather than a reactive decision.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating the transaction was scheduled in advance and not based on immediate, non-public information.
Negatives
- A director's sale of shares, even if pre-planned, reduces their direct ownership stake in the company.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This insider transaction report is specific to Ouster, Inc. and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The sale slightly reduces the direct ownership stake of a director, which could be perceived as a minor reduction in alignment, though the 10b5-1 plan context lessens this impact.
Key Dates
| Date | Description |
|---|---|
| 08/12/2025 | Date of the Rule 10b5-1 trading plan. |
| 11/11/2025 | Date of the reported transaction (sale of common stock). |
| 11/12/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Recommendation
holdA routine insider sale under a Rule 10b5-1 trading plan, especially of this relatively modest size, typically does not warrant a change in investment recommendation. These plans are pre-scheduled and do not usually signal new information about the company's prospects. Investors should continue to evaluate Ouster based on its fundamental performance and broader market conditions.
Keywords
Ouster, OUST, Form 4, Insider Transaction, Stock Sale, Director, Ted L. Tewksbury III, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.